CSIMarket
 


Kewaunee Scientific Corporation  (KEQU)
Other Ticker:  
 

Kewaunee Scientific's Working Capital Ratio

KEQU's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Kewaunee Scientific's Current Assets grew by 0.69 % in the IV Quarter 2024 sequentially, while Current Liabilities decreased, this led to improvement in Kewaunee Scientific's Working Capital Ratio to 2.37, above Kewaunee Scientific Corporation average Working Capital Ratio.

Within Laboratory Analytical Instruments industry 9 other companies have achieved higher Working Capital Ratio than Kewaunee Scientific in forth quarter 2024. While Working Capital Ratio total ranking in the forth quarter 2024 has deteriorated compared to the prior quarter from 1042 to 1356.

Explain Working Capital Ratio
How much in Current Assets KEQU´s has?
What is the value of KEQU´s Current Liabilities?


KEQU Working Capital Ratio (Apr 30 2024)
IV. Quarter
(Jan 31 2024)
III. Quarter
(Oct 31 2023)
II. Quarter
(Jul 31 2023)
I. Quarter
(Apr 30 2023)
IV. Quarter
Y / Y Current Liabilities Change 1.82 % -4.68 % -9.63 % -10.68 % -5.3 %
Y / Y Current Assets Change 10.12 % 5.02 % 0.29 % -4.36 % -3.98 %
Working Capital Ratio MRQ 2.37 2.28 2.35 2.11 2.2
KEQU's Total Ranking # 1356 # 1042 # 1864 # 2147 # 2154
Seq. Current Liabilities Change -3.23 % 8.8 % -12.43 % 10.43 % -9.41 %
Seq. Current Assets Change 0.69 % 5.81 % -2.83 % 6.37 % -3.98 %



Working Capital Ratio forth quarter 2024 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 10
Healthcare Sector # 407
Overall Market # 1356


Working Capital Ratio Statistics
High Average Low
2.68 2.2 1.45
(Apr 30 2014)   (Jan 31 2022)




Financial Statements
Kewaunee Scientific's Current Liabilities $ 41 Millions Visit KEQU's Balance sheet
Kewaunee Scientific's Current Assets $ 97 Millions Visit KEQU's Balance sheet
Source of KEQU's Sales Visit KEQU's Sales by Geography


Cumulative Kewaunee Scientific's Working Capital Ratio

KEQU's Working Capital Ratio for the trailling 12 Months

KEQU Working Capital Ratio

(Apr 30 2024)
IV. Quarter
(Jan 31 2024)
III. Quarter
(Oct 31 2023)
II. Quarter
(Jul 31 2023)
I. Quarter
(Apr 30 2023)
IV. Quarter
Y / Y Current Liabilities TTM Growth 1.82 % -4.68 % -9.63 % -10.68 % -5.3 %
Y / Y Current Assets TTM Growth 10.12 % 5.02 % 0.29 % -4.36 % -3.98 %
Working Capital Ratio TTM 2.27 2.23 2.18 2.12 2.08
Total Ranking TTM # 1028 # 2120 # 3717 # 4071 # 2884
Seq. Current Liabilities TTM Growth -3.23 % 8.8 % -12.43 % 10.43 % -9.41 %
Seq. Current Assets TTM Growth 0.69 % 5.81 % -2.83 % 6.37 % -3.98 %


On the trailing twelve months basis KEQU Current Assets increased by 10.12 % in IV Quarter 2024 year on year, faster than Current Liabilities, this led to increase in in Kewaunee Scientific's Working Capital Ratio to 2.27, above KEQU average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 10 other companies have achieved higher Working Capital Ratio than Kewaunee Scientific. While Working Capital Ratio overall ranking has improved so far to 1028, from total ranking during the twelve months ending third quarter 2023 at 2120.

Explain Working Capital Ratio
How much in Current Assets KEQU´s has?
What is the value of KEQU´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 11
Healthcare Sector # 389
Within the Market # 1028


trailing twelve months Working Capital Ratio Statistics
High Average Low
2.53 2.2 1.6
(Dec. 30, 2014)   (Jan 31 2022)




Companies with similar Working Capital Ratio in the quarter ending Apr 30 2024, within Laboratory Analytical Instruments Industry Working Capital RatioApr 30 2024 MRQ Current AssetsApr 30 2024 MRQ Current Liabilities
Lifeloc Technologies Inc   5.59 $ 5.073  Millions$ 0.907  Millions
Scientific Industries Inc   5.56 $ 11.400  Millions$ 2.050  Millions
10x Genomics Inc   5.22 $ 567.093  Millions$ 108.733  Millions
Akoya Biosciences Inc   3.07 $ 101.829  Millions$ 33.193  Millions
Kewaunee Scientific Corporation  2.37 $ 96.817  Millions$ 40.780  Millions
Revvity Inc  2.23 $ 3,059.340  Millions$ 1,374.222  Millions
Agilent Technologies inc   2.15 $ 4,203.000  Millions$ 1,958.000  Millions
Harvard Bioscience Inc  1.88 $ 48.148  Millions$ 25.677  Millions
Illumina Inc   1.75 $ 2,583.000  Millions$ 1,474.000  Millions
Avantor Inc   1.61 $ 2,321.100  Millions$ 1,441.900  Millions
Accelerate Diagnostics Inc   1.50 $ 24.133  Millions$ 16.131  Millions
Bionano Genomics Inc   1.46 $ 85.611  Millions$ 58.506  Millions
Mettler Toledo International Inc  1.28 $ 1,211.114  Millions$ 948.759  Millions
Precipio inc   0.91 $ 2.595  Millions$ 2.857  Millions
Thermogenesis Holdings Inc   0.52 $ 4.351  Millions$ 8.304  Millions

Date modified: 2024-06-29T12:19:21+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com